REVA PHARMA, is a fully integrated Healthcare and Pharmaceutical organization.
Licensing, Product Development, Contract Manufacturing and Healthcare Services form the
main activities of the company. Its operations and initiatives are backed up by regulatory
approved infrastructure, which help to offer its partners, Products & Services complying with
cGMP, GLP & EHS standards. It has carved out a name for itself in the Healthcare space
across geographies for Reliability, Transparency and Trust.
Since incorporation in 2009, it has moved up in the industry ranking, with emphasis on its
operations in Regulated, Expanding and Emerging markets. We have fulfilled our promise of
providing value added products and services to our clients with rewarding partnerships.
Dr Gurpreet Sandhu, CEO and founder of Reva Pharma receiving Pharma Leadership Award endorsed by the World Federation of Healthcare Professionals on 28th September 2019 at the Taj Mahal Hotel, New Delhi.
Article Name: 'India’s health diplomacy during a global pandemic and the Future of Pharma'
Updated on: 4th AUG 2020
Published On: BusinessWorld
Article Name: 'Since COVID, Biowaste Has Increased By 300 Per Cent'
Updated on: Jul 19, 2020, 20:40 IST
Published By: Anju Maskeri
Article Name: 'Making India self-sufficient'
Updated on: Aug 28, 2020
Published On: Express Pharma
Article Name: 'Remdesivir can put India centre stage once again during the Covid-19 pandemic'
Updated on: Aug 31, 2020
Published On: Times of India
Article Name: Covid-19 Restrictions Boost India’s Online Pharmacy Sector
Updated on: Sep 6, 2020
Published By: Rebecca Bundhun, The National
Article Name: Council For Healthcare And Pharma To Focus On Regulatory Reforms Issues
Updated on: Sep 8, 2020
Published By: Yash Ved, Pharmabiz
Article Name: Addressing Nitrosamine And Related Impurities In Pharmaceuticals
Published on: Sep 25, 2020
Published By: Bio Spectrum, India
Article Name: Interruption due to the pandemic in the continuum of care for heart patients can lead...
Published on: Sep 25, 2020
Published By: India.com
Article Name: CHP to offer expert consultative advice for setting up Medical Device and Pharma Parks in UP
Updated on: Oct 3, 2020
Published By: YashVed, PharmaBiz, Mumbai, India
Article Name: India has 0.75 psychiatrists per 100,000 people. Can telepsychiatry bridge the gap between mental health experts & patients.
Updated on: Oct 9, 2020
Published On: Economic Times
Article Name: "While the first round of vaccination for healthcare and essential services workers with an estimated strength..." Dr Gurpreet Sandhu, President - CHP.
Updated on: Oct 27, 2020
Published By: Neetu Chandra Sharma, Live Mint
Article Name: "The government needs to invest more in energy-efficient housing and power generation and manage industry..." Dr Gurpreet Sandhu, President - CHP
Updated on: Oct 28, 2020
Published By: Anisha Bhatia, NDTV
Article Name: Indian pharma industry calls on US FDA to conduct virtual inspections in the wake of COVID-19 pandemic: Dr Sandhu
Updated on: Oct 26, 2020
Published By: Yash Ved, Pharmabiz
Article Name: Lower winter temperatures and the rise in pollution levels... “ Dr Gurpreet Sandhu, President – Council for Healthcare & Pharma.
Updated on: Nov 3, 2020
Published By: Kritika Dua, The Daily Guardian
Article Name: Regardless of who occupies the White House, both India and the US... Dr Gurpreet Sandhu, President - Council for Healthcare & Pharma
Updated on: Nov 4, 2020
Published By: Business Today
Article Name: “Lower winter temperatures and the rise in pollution...” Dr Gurpreet Sandhu, president of Council for Healthcare & Pharma
Updated on: Nov 17, 2020
Published By: Kritika Dua, The Daily Guardian
Article Name: Role of Indian Pharma will likely grow under the Biden Administration
Updated on: Nov 24, 2020
Published On: The Times of India
"Our Mission is to provide Quality Pharmaceutical products and Healthcare services to our
global business partners, ensuring highest standards in manufacturing and laboratory
practices as well as compliance to Environment, Health and Safety norms. We are bound by
our motto: Caring for Healthier Lives.
Our Vision is to be the permanent partner of choice for the products and services that we
offer, by creating environment of Reliability, Transparency and Trust."
Our flagship markets are Japan, USA, Germany, Italy and Korea. We hold partnerships and alliances with Innovators, Biological, and Generic organizations the areas of Licensing, CRAM and API’s.
The UK became the first Western country to authorise a Covid-19 vaccine on Wednesday, marking a pivotal moment...
Pharmexil Director General lauds sector’s manufacturing abilities
Indian pharm...
Vaccine maker Serum Institute of India's CEO Adar Poonawalla has said the Oxford Covid-19 vaccine should be av...
© Copyright 2020 - All Rights Reserved Reva Pharma.
